Attention-Deficit Hyperactivity Disorder in Adults
Clinical Therapeutics 14:138-147, Bellak,L.&Black,R.B., 1992
Open Controlled Therapeutic Trial of Intravenous Immune Globulin in Relapsing-Remitting Multiple Sclerosis
Arch Neurol 49:1233-1236, Achiron,A.,et al, 1992
HIV-1 Infection and IV Drug Use:Longitudinal Neuropsych Eval of Asymptomatic Subjects
Neurol 42:1924-1930, Selnes,O.A.,et al, 1992
Cerebral Infarction Complicating Intravenous Immunoglobulin Therapy for Polyneuritis Cranialis
Neurol 42:257-258, Silbert,P.L.,et al, 1992
Transient Neutropenia Induced by Intravenous Immune Globulin
NEJM 326:270-271, Grebenau,M.D., 1992
Multifocal Demyelinating Motor Neuropathy:Cranial Nerve Involvement and Immunoglobulin Therapy
Neurol 42:506-509, Kaji,R.,et al, 1992
Multifocal Motor Neuropathy with Conduction Block:Is It a Distinct Clinical Entity?
Neurol 42:497-505, Lange,D.J.,et al, 1992
'De Novo'Absence Status of Late Onset:Report of 11 Cases
Neurol 42:104-110, Thomas,P.,et al, 1992
Intracranial Tuberculosis in AIDS:CT and MRI Findings
et al Neuroradiology 34:11-14, Villoria,M.F., 1992
Central Venous Catheters and Sepsis in Patients with Quadriplegia
NEJM 327:735-736, Walker,J.B.,et al, 1992
The Risk of Stroke in Patients with Acute Myocardial Infarction after Thrombolytic and Antithrombotic Treatment
NEJM 327:1-6, Maggioni,A.P.,et al, 1992
Intrinsic Spinal Cord Haemorrhage Due to Streptokinase Treatment for Myocardial Infarction
JNNP 55:740, Cruickshank,G.S.,et al, 1992
Urgent Therapy for Stroke Part II, Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes from Onset
Stroke 23:641-645, Haley,E.C.,et al, 1992
Urgent Therapy for Stroke Part I, Pilot Study of Tissue Plasminogen Activator Administered within 90 Minutes
Stroke 23:632-640, Brott,T.G.,et al, 1992
Intravenous Recombinant Tissue Plasminogen Activator in Acute Carotid Artery Territory Stroke
Neurol 42:976-982, Mori,E.,et al, 1992
Safety & Efficacy of Intravenous Tissue Plasminogen Activator & Heparin in Acute Middle Cerebral Artery Stroke
Stroke 23:646-652, vonKummer,R.&Hacke,W., 1992
Intracranial Hemorrhage After Coronoary Thrombolysis with Tissue Plsminogen Activator
Am J Med 92:384-390, Kase,C.S.,et al, 1992
Recombinant Tissue Plasminogen Activator in Acute Thrombotic and Embolic Stroke
Ann Neurol 32:78-86, delZoppo,G.J.,et al, 1992
Toxicity and Deaths from 3, 4-Methylenedioxymethamphetamine ("ecstast")
Lancet 340:384-387, Henry,J.A.,et al, 1992
Effect of Cocaine Use On the Fetus
NEJM 327:399-407, Volpe,J.J., 1992
CNS Complications of Cocaine Abuse:Prevalence, Pathophysiology, and Neuroradiology
AJR 159:137-147, Brown,E.,et al, 1992
Recurrent Aseptic Meningitis Complicating Intravenous Immunoglobulin Therapy for CIDP
Neurol 42:1636-1637, Vera-Ramirez,M.,et al, 1992
A Randomized Trial Comparins Intravenous Immune Globulin and Plasma Exchange in Guillain-Barre Syndrome
NEJM 326:1123-1129, VanDerMeche,F.G.A.,et al, 1992
Clinical and Electrophysiologic Improvement in Lambert-Eaton Syndrome with Intravenous Immunoglobulin Therapy
Neurol 42:1422-1423, Bird,S.J., 1992
Spinal Cord Toxoplasma Lesion in AIDS:MR Findings
J Comput Assist Tomogr 16:817-819, Poon,T.P.,et al, 1992
Stroke Complic Acute MI, A Meta-Analysis of Risk Modific by Antigoac & Thrombolytic Therapy
Arch Int Med 152:2020-2024, Viatkus,P.T.,et al, 1992
Thrombolysis in Acute Ischemic Stroke:Does it Work
Stroke 23:1826-1839, Wardlaw,J.M.&Warlow,C.P., 1992
Early Computed Tomographic Findings for Thrombolytic Therapy in Patients with Acute Brain Embolism
Stroke 23:20-23, Okada,Y.,et al, 1992
Concurrent Myocardial and Cerebral Infarctions after Intranasal Cocaine Use
Stroke 23:427-430, Sloan,M.A.&Mattioni,T.A., 1992
Cocaine-Related Vascular Headahces
JNNP 54:803-806, Dhuna,A.,et al, 1991
Cerebral Vasculitis Associated with Cocaine Abuse
Stroke 22:1437-1439, Fredericks,R.K.,et al, 1991
Cocaine as a Risk Factor for Acute Dystonic Reactions
Neurol 41:1670-1672, Hegarty,A.M.,et al, 1991
Maternal Cocaine Abuse:The Spectrum of Radiologic Abnormalities in the Neonatal CNS
AJR 157:1105-1110, Heier,L.A.,et al, 1991
HIV-1 Infection and Nervous System Abnormalities Among a Cohort of Intravenous Drug Users
Neurol 41:1905-1910, Royal III,W.,et al, 1991
Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome after Embolic Stroke
Arch Neurol 48:1235-1238, Zivin,J.A.&Mazzarella,V., 1991
Central Nervous System Infarction Related to Cocaine Abuse
Stroke 22:1320-1325, Daras,M.,et al, 1991
Acquired Pendular Nystagmus in Toluene Addiction
Neurol 41:282-285, Maas,E.F.,et al, 1991
Intravenous Immunoglobulin Treatment in Patients with Chronic Inflammatory Demyelinating Polyneuropathy
Arch Neurol 48:217-220, vanDoorn,P.A.,et al, 1991
Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with Intravenous Immunoglobulin
Ann Neurol 30:104-106, Cornblath,D.R.,et al, 1991
CIDP of Childhood:Treatment with High-Dose Intravenous Immunoglobulin
Neurol 41:828-830, Vedanarayanan,V.V.,et al, 1991
The Diagnosis of Childhood Neurodegenerative Disorders Presenting as Dementia in Adults
Neurol 41:794-798, Coker,S.B., 1991
Myasthenia Gravis Unmasked by Cocaine Abuse
NEJM 325:892, Berciano,J.,et al, 1991
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
CT patterns of Intracranial Hemorrhage Complicating Thrombolytic Therapy for Acute Myocardial Infarction
Radiology 181:555-559, Uglietta,J.P.,et al, 1991
Stroke After Heavy Marijuana Smoking
Stroke 22:406-409, Zachariah,S.B., 1991
Aseptic Meningitis Associated with High Dose Intravenous Immunoglobulin Therapy
JNNP 54:275-276, Watson,J.D.G.,et al, 1991
Clinicopath Conf
Cerebral Abscesses Complicating Embolic Cerebral Infarcts, Case 31-1991, NEJM 325:341-350991., , 1991
Intracerebral Hemorrhage
Stroke 22:684-691, Feldmann,E., 1991
Occurrence of Stroke Associated with Use/Abuse of Drugs
Neurol 41:1358-1364, Sloan,M.A.,et al, 1991
Fatal Brainstem Stroke Following Internal Jugular Vein Catheterization
Neurol 41:1092-1095, Sloan,M.A.,et al, 1991